Sturge-Weber Syndrome Market

ID: MRFR/HC/3661-CR

85 Pages

Rahul Gotadki

July 2019

Sturge-Weber Syndrome Market Research Report Information by Type (Type 1, Type 2 and Type 3), Diagnosis and Treatment (Treatment [Medication, Laser Therapy and Surgical Procedures], Diagnosis Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electroencephalogram (EEG) and Skull Radiography), End User (Hospital & Clinics, Diagnostic Centers) - Forecast till 2035

Sturge-Weber Syndrome Market Infographic

Single User

Multiple License

Enterprise User

Summary Table of Contents Segmentation Download PDF

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Certified Researchers

Customize Report

Sturge-Weber Syndrome Market Summary

The Global Sturge Weber Syndrome Market is projected to grow from 0.16 USD Billion in 2024 to 0.31 USD Billion by 2035.

Key Market Trends & Highlights

Sturge Weber Syndrome Key Trends and Highlights

The market is expected to witness a compound annual growth rate (CAGR) of 6.16% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 0.31 USD Billion, indicating a steady growth trajectory.
In 2024, the market is valued at 0.16 USD Billion, reflecting the current demand for treatment options.
Growing adoption of advanced therapeutic approaches due to increasing awareness of Sturge Weber Syndrome is a major market driver.

Sturge-Weber Syndrome Market

CAGR

6.16%

Market Size & Forecast

2024 Market Size	0.16 (USD Billion)
2035 Market Size	0.31 (USD Billion)
CAGR (2025-2035)	6.16%

Major Players

Shire (Ireland), ElectoCore LLC (US), GW Pharmaceuticals, PLC (US), Johnson and Johnson (US), Pfizer Inc. (US), Abbot (US), Aleva Neurotherapeutics SA (Switzerland), Hoffman-La Roche AG, Sanofi (France), UCB SA (Belgium)

Sturge-Weber Syndrome Market Drivers

Increasing Awareness and Diagnosis

The growing awareness surrounding Sturge Weber Syndrome is a pivotal driver for the Global Sturge Weber Syndrome Market Industry. Enhanced educational initiatives and outreach programs by healthcare organizations have led to improved diagnosis rates. As a result, more patients are being identified, which is crucial given that the market is projected to reach 0.16 USD Billion in 2024. This increased recognition not only facilitates timely intervention but also encourages research and development efforts aimed at better treatment options. Consequently, the rising number of diagnosed cases is likely to contribute to market growth, fostering a more informed patient population.

Market Segment Insights

Sturge Weber Syndrome Type Insights

On the basis of Type, the market is divided into Type 2, Type3, and Type 1.

Sturge Weber Syndrome End User Insights

On the basis of end-user, the Sturge Weber Syndrome Marketis divided into Diagnostic Centres, Clinics and Hospitals, and Others. In the year 2017, the clinics and hospitals segment accounted for a market value of USD 1,257.72 Million. Therefore, the revenue of this section will further increase in the forthcoming years.

Sturge Weber Syndrome Treatment Insights

On the basis of Treatment, the Sturge Weber Syndrome Market is divided into Surgical Procedure, and Laser Therapy. The laser treatment is further divided into medication which is again divided into Antiglaucoma and Antiepileptic. Furthermore, Antiglaucoma is divided into carbonic Anhydrase Inhibitors, Beta Antagonist Eye Drops, and Latanoprost.

The Diagnosis segment of the Sturge Weber Syndrome Global Market is divided into Skull Radiography, Magnetic resonance imaging (MRI), Electroencephalogram, and Computed Topography.

Get more detailed insights about Sturge-Weber Syndrome Market Research Report - Forecast till 2032

Request Free Sample

Key Companies in the Sturge-Weber Syndrome Market market include

Industry Developments

Shire in 2017 announced its FDA approval for its product called MYDAYIS. This is used for treating patients from the age of 13 and above.

UCB SA in 2018 acquired a nasal spray from a company called Promixagen. This acquisition will help UCB SA to enhance its portfolio in epilepsy treatment.

Novartis AG in 2018 acquired a company called AveXis. This acquisition is done for widening the portfolio in the sector of neuroscience and gene therapy.

Future Outlook

Sturge-Weber Syndrome Market Future Outlook

The Sturge Weber Syndrome Market is projected to grow at a 6.16% CAGR from 2024 to 2035, driven by advancements in treatment options and increased awareness.

New opportunities lie in:

Develop targeted therapies leveraging genetic insights for personalized treatment.
Expand telemedicine services to improve patient access and monitoring.
Invest in educational programs to raise awareness among healthcare professionals.

By 2035, the Sturge Weber Syndrome Market is expected to exhibit robust growth and enhanced treatment modalities.

Market Segmentation

Sturge Weber Syndrome Type Outlook

Type I
Type II
Type III

Sturge Weber Syndrome Region Outlook

North America
Asia-Pacific
Africa and the Middle East
Europe

Sturge Weber Syndrome Diagnosis and Treatment Outlook

DiagnosisElectroencephalogram (EEG) Skull Radiography Computer Tomography (CT) Scan Magnetic Resonance Imaging (MRI)
Electroencephalogram (EEG)
Skull Radiography
Computer Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
TreatmentSurgical Procedure Laser Therapy Medication AntiglaucomaCarbonic Anhydrase Inhibitors Beta Antagonist Eye Drops Latanoprost Others Antiepileptic
Surgical Procedure
Laser Therapy
Medication AntiglaucomaCarbonic Anhydrase Inhibitors Beta Antagonist Eye Drops Latanoprost Others
AntiglaucomaCarbonic Anhydrase Inhibitors Beta Antagonist Eye Drops Latanoprost Others
Carbonic Anhydrase Inhibitors
Beta Antagonist Eye Drops
Latanoprost
Others
Antiepileptic

Report Scope

Attribute/Metric	Details
Market Size 2023	0.15 Billion
Market Size 2024	0.16 Billion
Market Size 2032	0.26 Billion
CAGR	5.90%
Base Year	2023
Forecast Period	2024-2032
Historical Data	2022
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Diagnosis & Treatment, End User
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Abbott (US), Pfizer Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Novartis AG (Switzerland), UCB SA (Belgium), Sanofi (France), Shire (Ireland), Aleva Neurotherapeutics SA (Switzerland), GW Pharmaceuticals, PLC (US), ElectroCore LLC (US), and Johnson & Johnson (US)
Key Market Opportunities	New product launches and R&D Amongst major key Players
Key Market Drivers	Increasing prevalence of epilepsy and glaucoma Rising research and development Growing focus on players towards Sturge-Weber syndrome

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

At what CAGR is the sturge-weber syndrome market projected to grow during the forecast period?

Sturge-weber syndrome market is projected to grow at a 5.90% CAGR between 2024-2032.

Which region is expected to dominate the sturge-weber syndrome market?

The Americas is expected to dominate the sturge-weber syndrome market.

What will be the value of the sturge-weber syndrome market projected during the forecast period?

Sturge-weber syndrome market is predicted to touch USD 0.26 Billion by 2032.

Which end user segment will dominate the sturge-weber syndrome market?

Hospitals and clinics will dominate the sturge-weber syndrome market.

Which factors may limit the sturge-weber syndrome market growth?

Certain side effects may limit the sturge-weber syndrome market growth.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027